Finanshels

Free tool

What is your startup actually worth?

Seven valuation methods, weighted by the evidence you actually have, shown as a range rather than a number nobody can defend. Every figure carries its source, and the range narrows as you tell it more.

Your companySelects which comparables applyOpen
TractionThe hardest evidence you haveOpen
AED

Last twelve months, or ARR if you sell subscriptions

%

Year on year. Negative is allowed.

%

Revenue left after the cost of delivering it

AED

Enter a loss with a minus sign

Since you started, not since incorporation

Founders plus anyone full-time

Revenue qualitySeparates durable revenue from fragile revenueOpen
%

Share of total revenue

%

Above 100 means the base grows on its own

AED
AED
AED
The qualitative readHow pre-revenue methods price a company. Score honestly — an inflated five helps nobody.Open
Team
First-time founder, working aloneTeam who have built and exited this before
Product
Concept on paperShipped, used daily, hard to replicate
Market
Small or unprovenLarge, growing and clearly budgeted for
Traction
Nothing measurable yetCustomers pulling harder than you can serve
Defensibility
A competitor could copy this in a monthReal technical, data or regulatory advantage
The roundWhat raising actually costs youOpen
AED
%
%

Investors usually want this topped up before the round

Borrowing insteadWhether you need to sell equity at allOpen
AED

The base for receivables finance

AED
AED

Principal and interest already committed

Registered for UAE VAT
Audited financial statements
Security you could offer
UAE national owned

Estimated valuation

Idea stage

Nothing to value yet. Add revenue, or score the qualitative questions, and a range appears here.

Confidence

Indicative · 20/100

Too little evidence to be precise. Treat this as a direction, not a number.

Team strength would narrow this most

The heaviest single factor in every pre-revenue method.

Important disclaimer
This is an indicative valuation range built from published comparables and named valuation methods. It is not an offer, a fairness opinion, a valuation report, investment advice or tax advice, and Finanshels is not a licensed investment adviser. Every figure carries its source and the tool states plainly what it could not verify. Everything is computed in your browser from what you typed — nothing here has been reviewed by a person, and no lender has seen it. A real valuation is negotiated, and the number you agree depends on evidence, timing and leverage this tool cannot see. UAE lending criteria shown are what each named provider publishes on its own pages; approval is always a credit decision made by the lender. Speak to a qualified adviser before acting on any of it.

Startup valuation, explained properly

What the methods actually do, what the benchmarks really say, and where the data runs out.

How do you actually value a startup?

There is no single formula, which is why this tool runs seven and shows you the spread. For a company with no revenue, the established methods are qualitative: Berkus scores five value drivers at up to $500,000 each, the Scorecard method compares you against the median funded company in your region, and Risk Factor Summation adjusts that median across twelve named risks. Once revenue exists, comparables take over — a sector revenue multiple adjusted for growth, margin and retention, and an EBITDA multiple once you are profitable. The VC method works backwards from a plausible exit and the return an investor needs. A discounted cash flow is included for completeness but weighted lightly, because at early stage the terminal value dominates the answer and the terminal value is an assumption.

Why does this show a range instead of one number?

Because a single number is the defining dishonesty of free valuation calculators. Founders quote it in rooms where it then has to survive contact with a real investor. The methods here frequently disagree by a factor of two or more on the same company, and that disagreement is information about how little the evidence constrains the answer. The published range widens as confidence falls, so a thinly-evidenced valuation physically looks less precise rather than merely carrying a caveat underneath.

What revenue multiple should a startup use?

Not the one you see quoted for listed companies. Damodaran's January 2026 dataset puts listed system and application software at 11.4 times revenue, but applying that to a private startup overstates its value badly, because a listed multiple prices liquidity, continuous disclosure and scale a startup does not have. Where somebody publishes a private-company figure it is better evidence: SaaS Capital predicts 4.8 times ARR bootstrapped and 5.3 times equity-backed, fitted across more than 1,500 private B2B SaaS companies. That is a model calibrated to private companies rather than a record of private transactions, and it predates a reported fall in public multiples, so treat it as generous rather than mean. This tool uses it where it exists, and applies an explicit 30% listed-to-private discount where it has to work from a public comparable.

How much does growth change a startup's valuation?

More than any other single input. SaaS Capital publishes a regression whose coefficients imply that each additional 10 percentage points of ARR growth is worth roughly 0.83 turns of revenue multiple, and each 10 points of net revenue retention roughly 0.26 turns. Two companies at identical revenue can therefore be worth several times apart on growth alone. That is why this tool refuses to apply a growth adjustment at all when you have not supplied a growth rate — it widens the range instead and tells you what supplying it would be worth.

What are typical pre-money valuations by stage?

The PitchBook-NVCA Venture Monitor puts the US median seed pre-money at $18.4 million as of 31 March 2026, Series A at $64.0 million and Series B at $188.3 million as of 30 June 2026. Two caveats matter more than the numbers. These are medians of companies that successfully raised, so the median company that tried and failed is in no dataset. And no primary source publishes a pre-seed median at all, so any figure you see for that stage is somebody's estimate.

Are there UAE or MENA startup valuation benchmarks?

Not credibly, and pretending otherwise would be the easiest way for this tool to be wrong. No public source publishes median pre-money valuations by stage for the UAE, the GCC or MENA. The two datasets that cover regional funding at all report totals and deal counts rather than valuations, and they disagree with each other by roughly a quarter on the same half-year. This tool therefore discounts a sourced US anchor for the region and says explicitly that the regional adjustment is its own assumption rather than a published figure.

Should I raise equity or borrow instead?

Equity is permanent and debt is not, and founders routinely underestimate what equity costs because the two costs arrive in different currencies at different moments. Debt costs interest, visibly, this year. Equity costs a percentage, invisibly, at exit — selling 20% of a company that later sells for ten times more did not cost you the raise amount, it cost you ten times the raise amount. This tool computes the all-in borrowing rate at which debt would cost exactly what the equity does, so you can hold it against a real quote rather than against a guess.

What do UAE banks require to lend to an SME?

Mostly they do not say. Of nine major UAE lenders checked, the majority publish facility ceilings and adjectives but no turnover floor, no trading-history requirement and no rate. Dubai Islamic Bank is the clearest exception, publishing two years incorporated, AED 1 million minimum turnover, facilities up to AED 2 million over six to thirty-six months, and profit rates of 15% to 22% — an Islamic profit rate, not conventional interest. RAKBANK advertises up to AED 5 million collateral-free over sixty months but publishes neither criteria nor a rate. All figures were read from the banks' own pages on 7 September 2026 and change without notice, so confirm anything you plan to rely on. The detailed criteria circulating on comparison sites trace to no bank and no regulator, so this tool does not use them.

Can a loss-making company still borrow in the UAE?

A term loan is repaid out of profit, so with no profit there is no earnings-based capacity — but that does not close every door. Receivables finance is secured on invoices rather than earnings. Beehive, a DIFC platform regulated by the DFSA rather than a bank, publishes advances of up to 80% of outstanding receivables on invoices due within 120 days, from 1.17% per month. That distinction between earnings-based and asset-based lending is why this tool assesses each facility separately rather than producing a single borrowing number.

How much of my company will I give up in a round?

More than the headline dilution, usually. If you raise AED 5 million at a AED 20 million pre-money, the post-money is AED 25 million and the investor takes 20%. What often goes unmentioned in the room is the option pool top-up: investors commonly require the pool to be topped up before the round, and that top-up comes out of the existing holders rather than the new money. It is founder dilution under a different name, and this tool models it explicitly.

Does the AED to USD exchange rate affect my valuation?

No, and that is unusually convenient for UAE founders. The dirham is pegged to the US dollar at 3.6725 by the Central Bank of the UAE, not floated, so a valuation quoted in dollars converts to dirhams exactly with no FX assumption hiding inside it. Every comparable multiple and stage benchmark in this tool is dollar-denominated, so the conversion is applied once and is exact. UAE interest rates track US Federal Reserve policy for the same reason.

Is this valuation good enough to show an investor?

It is a defensible opening position with the reasoning attached, which is more than most founders bring, and it is not a valuation opinion. Every figure carries its source and the report states plainly what it could not verify. What it cannot see is your pipeline quality, your team's actual execution, what your competitors are raising at this month, and how badly the investor across the table wants the deal. A real valuation is negotiated, and the number you agree depends on evidence, timing and leverage no calculator can model.